Click a link below to view the mailing archive as if it had been sent to you.
| 2017-06-30 12:15 | | The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion) and more... |
| 2017-06-30 00:15 | | Medtech M&A: The 10 biggest deals so far in 2017 and more... |
| 2017-06-29 12:15 | | Details on surprise Novartis heart drug success due Aug 27 and more... |
| 2017-06-29 00:15 | | 5 Biotech Stocks With Major Catalysts in July and more... |
| 2017-06-28 12:15 | | Price-hike king Valeant could be hit hardest by FDA generics push: analyst and more... |
| 2017-06-28 00:15 | | Merck targeted in global ransomware attack and more... |
| 2017-06-27 12:15 | | Shocker: Merck Cholesterol Drug Yields Benefit Where Rivals Failed and more... |
| 2017-06-27 00:15 | | Pfizer’s Xeljanz: Results from the ORAL Strategy and more... |
| 2017-06-26 12:15 | | The Liabilities of Pharmacovigilance Activities and more... |
| 2017-06-26 00:15 | | Astellas UK narrowly dodges expulsion after more trouble with Britain's pharma cops and more... |
| 2017-06-25 12:15 | | The FDA Has Never Approved a Drug Like This in Its 111-Year History and more... |
| 2017-06-24 12:15 | | Could Merck and Leap union be the one for Keytruda? and more... |
| 2017-06-24 00:15 | | AbbVie's Eagerly Anticipated Followup to Humira Is Coming: What You Need to Know and more... |
| 2017-06-23 12:15 | | What we know from BIO2017 and more... |
| 2017-06-23 00:15 | | Scenes From Martin Shkreli’s Journey to Federal Court and more... |
| 2017-06-22 12:15 | | Novartis Drug Becomes First To Prevent Heart Attacks And Strokes By Targeting Inflammation and more... |
| 2017-06-22 00:15 | | These 3 Biotechs Have Been Crushed and more... |
| 2017-06-21 12:15 | | Mylan cut its tax rate into the single digits by investing in coal: Reuters and more... |
| 2017-06-21 00:15 | | Intuitive Surgical wins FDA nod for inguinal hernia repairs with da Vinci Xi and more... |
| 2017-06-20 12:15 | | Worldwide drug sale forecasts fall as pricing pressures mount and more... |
| 2017-06-20 00:15 | | Stryker to pay $700m for Novadaq and more... |
| 2017-06-19 12:15 | | How Are Whistleblowers Paid and more... |
| 2017-06-19 00:15 | | Why Amazon’s Whole Foods Deal Is Slamming Pharma Stocks, Too and more... |
| 2017-06-18 00:15 | | Eli Lilly CEO David Ricks weighs in on drug costs and health reform and more... |
| 2017-06-17 00:15 | | Sanofi chief says U.S. Supreme Court ruling on biologics has "immediate impact" and more... |
| 2017-06-16 12:15 | | Johnson & Johnson closes $30B Actelion buyout and more... |
| 2017-06-16 00:15 | | The myth of “leaner and meaner” pharma and more... |
| 2017-06-15 12:15 | | 5 Things You Didn't Know About Eli Lilly and Co and more... |
| 2017-06-15 00:15 | | Want to earn more, pharma reps? Go large, get on the road or jump to biotech and more... |
| 2017-06-14 12:15 | | J&J, Pfizer, Merck sit atop Fortune's 500 for pharma and more... |
| 2017-06-14 00:15 | | Is Mallinckrodt in Talks to Be Sold? and more... |
| 2017-06-13 12:15 | | Acceleron dumps dalantercept after kidney cancer trial fail and more... |
| 2017-06-13 00:15 | | J&J Drug Prevents Heart Attacks At Cost Of Amputated Toes and more... |
| 2017-06-12 12:15 | | Consumers don't find pharma all that innovative now, but there's hope for the future: Study and more... |
| 2017-06-12 00:15 | | First PhIII trial of AbbVie’s upadacitinib a success and more... |
| 2017-06-11 12:15 | | ADA preview: 5 things to watch in diabetes and more... |
| 2017-06-11 00:15 | | Johnson & Johnson wins last regulatory nod needed for Actelion acquisition and more... |
| 2017-06-10 00:15 | | Proove Biosciences Responds to News About FBI Raid |
| 2017-06-09 12:15 | | Stryker leaves ex-reps out of it in poaching suit against Zimmer Biomet and more... |
| 2017-06-09 00:15 | | In A First, FDA Requests An Opioid Be Pulled From The Market and more... |
| 2017-06-08 12:15 | | Top 10 diabetes drugs by 2016 sales and more... |
| 2017-06-08 00:15 | | Medtronic’s long-awaited ‘artificial pancreas’ makes U.S. debut and more... |
| 2017-06-07 12:15 | | PhRMA's big-spending image campaign has hit $20M, and new spots are rolling out and more... |
| 2017-06-07 00:15 | | ASCO17: Juno marks progress with second-gen CAR-T and more... |
| 2017-06-06 12:15 | | ASCO dark horse Nanjing Legend Biotech shines with promising CAR-T data and more... |
| 2017-06-06 00:15 | | ASCO17: Merck touts Keytruda bladder benefit post Tecentriq failure and more... |
| 2017-06-05 12:15 | | Merck (MRK) Up 2.3% Since Earnings Report: Can It Continue? and more... |
| 2017-06-04 12:15 | | AstraZeneca's Lynparza Slows Breast Cancer Caused By BRCA Mutations By 42% and more... |
| 2017-06-03 12:15 | | How Did Bristol Lose An Edge In Lung Cancer? It's No Mystery, Says New R&D Boss and more... |
| 2017-06-02 12:15 | | At big cancer meeting, a big question: Is the U.S. ‘losing its edge’ and more... |
| 2017-06-02 00:15 | | ViiV, GSK gamble a surprise $130M chip in a high-stakes HIV playoff with Gilead and more... |
| 2017-06-01 12:15 | | Maryland Gov. allows drug price gouging bill to become law and more... |
| 2017-06-01 00:15 | | Merck Ventures leads $11M round in solid tumor startup and more... |
